Late Breaking Abstracts LBA 1 Two Years of AntiAndrogen Treatment Increases Other-Cause Mortality in Men Receiving Early Salvage Radiotherapy : A Secondary Analysis of the NRG Oncology / RTOG 9601 Randomized Phase III Trial

D.E. Spratt, R.T. Dess, J.A. Efstathiou, A.L. Zietman, D.G. Wallington, N.K. Jairath, W.C. Jackson, R.B. Den, B.J. Stish, T.M. Morgan, J.J. Dignam, T.M. Pisansky, S.A. Rosenthal, J.M. Michalski, O. Sartor, F.Y. Feng, M. Schipper, H.M. Sandler, Y. Sun, and W.U. Shipley; Department of Radiation Oncology, University of Michigan, Ann Arbor, MI, Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, Massachusetts General Hospital, Boston, MA, Western Michigan, Ann Arbor, MI, University of Michigan, Ann Arbor, MI, Dept of Radiation Oncology, Sidney Kimmel Medical College & Cancer Center at Thomas Jefferson University, Philadelphia, PA, Thomas Jefferson, Philadelphia, PA, Department of Radiation Oncology, Mayo Clinic, Rochester, MN, Department of Urology, University of Michigan, Ann Arbor, MI, University of Chicago, Department of Public Health Sciences, Chicago, IL, Sutter Medical Group and Cancer Center, Sacramento, CA, Washington University School of Medicine, St. Louis, MO, Tulane University, New Orleans, LA, Department of Radiation Oncology, University of California San Francisco, San Francisco, CA, Michigan Medicine, Department of Radiation Oncology, University of Michigan Rogel Cancer Center, Ann Arbor, MI, Cedars Sinai Medical Center, Los Angeles, CA, Department of Biostatistics, University of Michigan, Ann Arbor, MI